Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lilly partners with API to launch a CME for obesity
The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…
Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData
Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…
Pharmexcil urges balance between compliance and commerce to safeguard India’s export momentum and…
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has expressed urgent concerns over the recent circular issued…
bioMérieux – Endotoxin Testing (rFC) – Decoding the future of endotoxin testing
After 50 years of LAL testing, the pharmaceutical industry is transitioning to recombinant Factor C (rFC) methods. USP Chapter…
IGI and AbbVie announce exclusive global licensing agreement for ISB 2001
IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…
XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer:…
Pfizer and Astellas Pharma has announced positive topline results from the overall survival (OS) analysis from the Phase 3 EMBARK…
Sai Parenterals secures $5.82M equity investment from Marquee investors
Sai Parenterals has announced the successful completion of a USD 5.82 million (Rs 50 crore) equity investment round by a group of…
Lupin signs license and supply agreement with Zentiva for commercialising Certolizumab
Lupin and a pan-European pharmaceutical company, Zentiva have entered into a license and supply agreement for commercialisation of…
Syngene International announces third year of STEM scholarship for women
Syngene International in partnership with the Research and Innovation Circle of Hyderabad (RICH) and Biocon Foundation, announced…